This is also true for high-risk patients, that is, patients already diagnosed with prediabetes, in whom a combination of decreased baseline insulin sensitivity and secretion appears to act additively to increase the risk for T2D development over time [27]. This evidence concerns the gene INS and prediabetes syndrome.